Skip to content
  • Home
  • About Us
  • Services
  • Courses
  • Online Learning
  • News and Events
  • Contact Us
  • Home
  • About Us
  • Services
  • Courses
  • Online Learning
  • News and Events
  • Contact Us

Revio

  1. Home>
  2. News and Events>
  3. Revio
Read more about the article EMA’s Update on Scientific Recommendations on Classification of ATMPs

EMA’s Update on Scientific Recommendations on Classification of ATMPs

  • Post published:May 26, 2022

Today, from Revio, we would like to share with you the latest updates on the scientific recommendations that European Medicines Agency’s Committee for Advanced Therapies (CAT) delivers on whether a…

Continue ReadingEMA’s Update on Scientific Recommendations on Classification of ATMPs

Revio is a Regulatory Affairs Consultancy – Created to support biopharmaceutical companies and public institutions, working with Advanced Therapy Medicinal Products (ATMPs)

Facebook-f Twitter Pinterest Linkedin

About

Home

About Us

Services

News & Events

Contact Us

Contact

TELEPHONES

+34 656 659 636

EMAIL

regaffairs@reviopharma.com

Legal

Cookies Policy

Data Protection

Legal Notice

Privacy policy

Social Networks

Copyright © 2024 – All Right Reserved – Powered by: Headteam.marketing

Reviopharma
×

Cart